United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  error! hyperlink reference not valid. and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see  warnings  and  dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated du

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dupilumab, quantity: 175 mg/ml - injection, solution - excipient ingredients: arginine hydrochloride; histidine; polysorbate 80; sodium acetate; glacial acetic acid; sucrose; water for injections - dupixent is indicated for the following type 2 inflammatory diseases:,atopic dermatitis,adults and adolescents,dupixent is indicated for the treatment of moderate to severe atopic dermatitis in patients aged 12 years and older who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,children 6 months to 11 years of age,dupixent is indicated for the treatment of severe atopic dermatitis in patients aged 6 months to 11 years old who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,asthma,dupixent is indicated as add on maintenance treatment in patients aged 6 years and older with moderate to severe asthma with type 2 inflammation (elevated eosinophils or elevated feno) that is inadequately controlled despite therapy with other medicinal products for maintenance treatment (see section 5.1 pharmacodynamic properties ? clinical trials).,chronic rhinosinusitis with nasal polyposis (crswnp),dupixent is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (crswnp).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dupilumab, quantity: 175 mg/ml - injection, solution - excipient ingredients: arginine hydrochloride; histidine; polysorbate 80; sodium acetate; glacial acetic acid; sucrose; water for injections - dupixent is indicated for the following type 2 inflammatory diseases:,atopic dermatitis,adults and adolescents,dupixent is indicated for the treatment of moderate to severe atopic dermatitis in patients aged 12 years and older who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,children 6 months to 11 years of age,dupixent is indicated for the treatment of severe atopic dermatitis in patients aged 6 months to 11 years old who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,asthma,dupixent is indicated as add on maintenance treatment in patients aged 6 years and older with moderate to severe asthma with type 2 inflammation (elevated eosinophils or elevated feno) that is inadequately controlled despite therapy with other medicinal products for maintenance treatment (see section 5.1 pharmacodynamic properties ? clinical trials).,chronic rhinosinusitis with nasal polyposis (crswnp),dupixent is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (crswnp).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dupilumab, quantity: 150 mg/ml - injection, solution - excipient ingredients: arginine hydrochloride; water for injections; polysorbate 80; sucrose; histidine; glacial acetic acid; sodium acetate trihydrate - dupixent is indicated for the following type 2 inflammatory diseases:,atopic dermatitis,adults and adolescents dupixent is indicated for the treatment of moderate to severe atopic dermatitis in patients aged 12 years and older who are candidates for chronic systemic therapy. dupixent is not intended for episodic use. children 6 to 11 years of age dupixent is indicated for the treatment of severe atopic dermatitis in patients aged 6 to 11 years old who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,asthma,dupixent is indicated as add on maintenance treatment in patients aged 6 years and older with moderate to severe asthma with type 2 inflammation (elevated eosinophils or elevated feno) that is inadequately controlled despite therapy with other medicinal products for maintenance treatment (see section 5.1 pharmacodynamic properties ? clinical trials).,chronic rhinosinusitis with nasal polyposis (crswnp),dupixent is indicated as an add-on maintenance treatment in adult p

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dupilumab, quantity: 150 mg/ml - injection, solution - excipient ingredients: arginine hydrochloride; water for injections; polysorbate 80; sucrose; histidine; glacial acetic acid; sodium acetate trihydrate - dupixent is indicated for the following type 2 inflammatory diseases:,atopic dermatitis,adults and adolescents,dupixent is indicated for the treatment of moderate to severe atopic dermatitis in patients aged 12 years and older who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,children 6 to 11 years of age,dupixent is indicated for the treatment of severe atopic dermatitis in patients aged 6 to 11 years old who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,prurigo nodularis,dupixent is indicated for the treatment of moderate-to-severe prurigo nodularis (pn) in adults who are candidates for systemic therapy.,asthma,dupixent is indicated as add on maintenance treatment in patients aged 6 years and older with moderate to severe asthma with type 2 inflammation (elevated eosinophils or elevated feno) that is inadequately controlled despite therapy with other medicinal products for maintenance treatment (see section 5.1 pharmacodynamic properties ? clinical trials).,chronic rhinosinusitis with nasal polyposis (crswnp),dupixent is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (crswnp). dupixent is indicated for the following type 2 inflammatory diseases:,atopic dermatitis,adults and adolescents,dupixent is indicated for the treatment of moderate to severe atopic dermatitis in patients aged 12 years and older who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,children 6 months to 11 years of age,dupixent is indicated for the treatment of severe atopic dermatitis in patients aged 6 months to 11 years old who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,asthma,dupixent is indicated as add on maintenance treatment in patients aged 6 years and older with moderate to severe asthma with type 2 inflammation (elevated eosinophils or elevated feno) that is inadequately controlled despite therapy with other medicinal products for maintenance treatment (see section 5.1 pharmacodynamic properties ? clinical trials).,chronic rhinosinusitis with nasal polyposis (crswnp),dupixent is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (crswnp).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dupilumab, quantity: 150 mg/ml - injection, solution - excipient ingredients: arginine hydrochloride; water for injections; polysorbate 80; sucrose; histidine; glacial acetic acid; sodium acetate trihydrate - dupixent is indicated for the following type 2 inflammatory diseases:,atopic dermatitis,adults and adolescents,dupixent is indicated for the treatment of moderate to severe atopic dermatitis in patients aged 12 years and older who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,children 6 to 11 years of age,dupixent is indicated for the treatment of severe atopic dermatitis in patients aged 6 to 11 years old who are candidates for chronic systemic therapy. dupixent is not intended for episodic use.,prurigo nodularis,dupixent is indicated for the treatment of moderate-to-severe prurigo nodularis (pn) in adults who are candidates for systemic therapy.,asthma,dupixent is indicated as add on maintenance treatment in patients aged 6 years and older with moderate to severe asthma with type 2 inflammation (elevated eosinophils or elevated feno) that is inadequately controlled despite therapy with other medicinal products for maintenance treatment (see section 5.1 pharmacodynamic properties ? clinical trials).,chronic rhinosinusitis with nasal polyposis (crswnp),dupixent is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (crswnp).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

du pont (australia) ltd - trifluralin - herbicide - barley | broccoli | brussels sprouts | cabbage | canola oilseed crop | carrot | cauliflower | cotton | field pea | green bean | - annual or wimmera ryegrass | barnyard or water grass | brome grass | caltrop or yellow vine | canary grass | capeweed | columbus grass | fumitory | guinea grass | johnson grass | liverseed or urochloa grass | mossman river or burr grass | perennial pigweed | phalaris | radish | redroot or redroot amaranth | redshank,slim or spleen amaranth | summer or crab grass | three cornered jack or doublegee | wild or black oat | wild turnip | winter grass | wireweed, knotweed or hogweed | amaranthus cruentus | annual blue grass | annual phalaris | annual poa | annual summer grass | australian phalaris | barnyard grass | bindy-eye | brassica campestris | brassica rapa ssp. sylvestris | brassica rapa var. sylvestris | bromus diandrus | bromus rigidus | bullhead | bull's head | caltrop burr | cathead | cat's-head | fallopia aviculare | goat's-head | goose grass | liverseed grass | mossman burr grass | neverdie | perennial phalaris | phalaris tuberosa-old si name | pigweed | pink weed | polygonum persicaria | prince of wale

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

du pont (australia) ltd - metsulfuron-methyl ester - herbicide - commercial area - general | flood plain | industrial land or area | pasture | right-of-way - general | high intensity usage - alligator weed | apple box | australian or native blackthorn | bellyache bush | bitou bush or boneseed | blackberry | blakely's red gum or gum | bracken | bridal creeper | crofton weed | darling pea | fennel | furze or gorse | golden dodder | great mullein | hawthorn | inkweed | japanese sunflower | kangaroo thorn | lantana - lantana camara | messmate stringybark | mimosa pigra | mistflower or creeping crofton weed | narrowleaf peppermint | noogoora burr | parthenium weed | paterson's curse | privet | ragwort | rubber vine | sweet briar or wild rose | tree-of-heaven | wait-a-while | wild turnip | yellow box | austral bracken | azzarola | blackberry with st john's wort | brassica campestris | brassica rapa ssp. sylvestris | brassica rapa var. sylvestris | c. monilifera ssp. monilifera | c. monilifera ssp. rotunda | common bracken | common lantana | common mullein | cotton weed | crataegus laevigata | crataegus sinaica | crataegus spp. | echium lycopsis | echium spp. | eucalyptus radiata ssp. robert | eucalyptu

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

du pont (australia) ltd - hexazinone - herbicide - bare ground - non-crop or forage area | commercial area - general | flood plain | industrial land or area | right-of-way - gener - blady grass | bracken | brome - seedling | brown stringybark | bushy starwort or wild aster | canadian fleabane | clover | clover - seedling | cobbler's pegs | couch grass | dock | dogwood,common cassinia or dollybush | giant or black pigweed | green amaranth | kangaroo grass | medic | medic - seedling | messmate stringybark | mexican or prickly poppy | mimosa pigra | narrowleaf peppermint | native bluebell | nutgrass | paspalum | purple top | queensland bluegrass | red natal grass | rhodes grass | ribwort, ribgrass or lamb's tongue | ryegrass | ryegrass - seedling | silver wattle | summer or crab grass | tarvine | veined verbena | volunteer lupin - seedling | wild or black oat | wild or black oat - seedling | abyssinian rhodes grass | annual medic | annual summer grass | argemone ochroleuca | austral bracken | australian bluebell | black pigweed | blue top | boerhavia diffusa | boerhavia repanda | broadleaf dock | burr medic | cluster flower vervain | cluster-flower verbena | common bracken | common cassinia

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

du pont (australia) ltd - hexazinone - herbicide - agricultural/farm buildings | bare ground - non-crop or forage area | commercial/industrial land | right-of-way - general | anim - acacia genus | blady grass | bracken | brome - seedling | brown stringybark | bushy starwort or wild aster | canadian fleabane | clover | clover - seedling | cobbler's pegs | couch grass | dock | dogwood,common cassinia or dollybush | giant or black pigweed | green amaranth | kangaroo grass | medic | medic - seedling | messmate stringybark | mexican or prickly poppy | narrowleaf peppermint | native bluebell | nutgrass | paspalum | purple top | queensland bluegrass | red natal grass | rhodes grass | ribwort, ribgrass or lamb's tongue | ryegrass | ryegrass - seedling | summer or crab grass - d. ciliaris | tarvine | veined verbena | volunteer lupin - seedling | wild or black oat | wild or black oat - seedling | abyssinian rhodes grass | annual medic | argemone ochroleuca | austral bracken | australian bluebell | black pigweed | black wattle | blue top | boerhavia diffusa | boerhavia repanda | brigalow (acacia harpophylla) | broadleaf dock | burr medic | cluster flower vervain | cluster-flower verbena | common br